Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Alt
Recent news which mentions Alt
< Previous
1
2
3
4
5
6
7
8
Next >
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Tickers
ACRX
ADCT
AEY
AGL
Tags
LZ
NTCO
AVCT
From
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Tickers
ACRX
AEY
AIRS
ALT
Tags
PSHG
USIO
PTE
From
Benzinga
B. Riley Securities Maintains Buy Rating for Altimmune: Here's What You Need To Know
August 12, 2022
Tickers
ALT
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
August 12, 2022
Tickers
ALT
ANTX
BEKE
CHPT
Tags
RANI
JOBY
Specialty Chemicals
From
Benzinga
ALTIMMUNE INC (ALT) Q2 2022 Earnings Call Transcript
August 11, 2022
Tickers
ALT
Tags
Recent Press Releases
Market News
ALT
From
Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 03, 2022
Tickers
ALNY
ALT
APDN
BBIO
Tags
PSTX
EAR
MSPR
From
Benzinga
7 Biotech Stocks to Buy for Q3
July 18, 2022
Tickers
ALT
AMLX
ARQT
AXSM
Tags
AMLX
Market News
ICPT
From
InvestorPlace
89 Biggest Movers From Friday
June 21, 2022
Tickers
ADN
ADXN
AKRO
ALLK
Tags
AKRO
SANA
REE
From
Benzinga
69 Biggest Movers From Yesterday
June 10, 2022
Tickers
ABM
ACLX
ALLR
ALNA
Tags
SONN
SJ
News
From
Benzinga
Piper Sandler Maintains Overweight Rating for Altimmune: Here's What You Need To Know
May 18, 2022
Tickers
ALT
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
110 Biggest Movers From Friday
May 16, 2022
Tickers
AFI
AFRM
AI
ALT
Tags
CLSK
LPTH
STEM
From
Benzinga
ALTIMMUNE INC (ALT) Q1 2022 Earnings Call Transcript
May 12, 2022
Tickers
ALT
Tags
Market News
Recent Press Releases
ALT
From
Motley Fool
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
May 12, 2022
Tickers
ACOR
ALT
BBI
BBIO
Tags
SLRX
Contracts
BBIO
From
Benzinga
Altimmune: Q1 Earnings Insights
May 12, 2022
Tickers
ALT
Tags
BZI/Recaps
Benzinga
Market News
From
Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
May 09, 2022
Tickers
ADMA
ALT
BHC
BMRN
Tags
IPOs
Earnings
OSUR
From
Benzinga
Altimmune Earnings Perspective: Return On Capital Employed
March 16, 2022
Tickers
ALT
Tags
Benzinga
Market News
Earnings
From
Benzinga
ALTIMMUNE INC (ALT) Q4 2021 Earnings Call Transcript
March 15, 2022
Tickers
ALT
Tags
ALT
Recent Press Releases
Market News
From
Motley Fool
Altimmune: Q4 Earnings Insights
March 15, 2022
Tickers
ALT
Tags
News
Earnings
Market News
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
IBB
FDA
BTTX
From
Benzinga
Earnings Scheduled For March 14, 2022
March 14, 2022
Tickers
ACHR
ADAP
AGRO
AKYA
Tags
DLO
BZI/UE
LRFC
From
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Tickers
ACIU
ADAP
ALDX
ALEC
Tags
ETON
ADAP
ALEC
From
Benzinga
Altimmune's Earnings Outlook
March 11, 2022
Tickers
ALT
Tags
ALT
BZI/EP
Earnings
From
Benzinga
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
February 08, 2022
Tickers
ALT
AZN
JNJ
MRNA
Tags
Recent Press Releases
PFE
JNJ
From
Motley Fool
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
January 31, 2022
Tickers
ALT
Tags
Market News
Benzinga
Briefs
From
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 30, 2021
Tickers
ALRN
ALT
KLDO
KPRX
Tags
PDSB
LXRX
LIXT
From
Benzinga
ALTIMMUNE INC (ALT) Q3 2021 Earnings Call Transcript
November 11, 2021
Tickers
ALT
Tags
Recent Press Releases
Market News
ALT
From
Motley Fool
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Tickers
ABBV
ADMA
AGTC
AIM
Tags
M&A
AZN
INM
From
Benzinga
52 Biggest Movers From Yesterday
September 30, 2021
Tickers
ABVC
ACY
AGIL
ALT
Tags
ACY
MIGI
EM
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 29, 2021
Tickers
ALT
BPTS
DRMA
EDIT
Tags
PROG
EDIT
NCNA
From
Benzinga
33 Stocks Moving In Wednesday's Mid-Day Session
September 29, 2021
Tickers
ABVC
ALT
ANNX
ARQQ
Tags
ABVC
Small Cap
Penny Stocks
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today